Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313361181> ?p ?o ?g. }
- W4313361181 endingPage "106" @default.
- W4313361181 startingPage "106" @default.
- W4313361181 abstract "Precision oncology has been increasingly used in clinical practice and rapidly evolving in the oncology field. Thus, this study was performed to assess the frequency of germline mutations in early and late onset familial breast cancer (BC) Egyptian patients using multi-gene panel sequencing to better understand the contribution of the inherited germline mutations in BC predisposition. Moreover, to determine the actionable deleterious mutations associated with familial BC that might be used as biomarker for early cancer detection.Whole blood samples were collected from 101 Egyptian patients selected for BC family history, in addition to 50 age-matched healthy controls. A QIAseq targeted DNA panel (human BC panel) was used to assess the frequency of germline mutations.A total of 58 patients (57.4%) out of 101 were found to have 27 deleterious germline mutations in 11 cancer susceptibility genes. Of them, 32 (31.6%) patients carried more than one pathogenic mutation and each one carried at least one pathogenic mutation. The major genes harboring the pathogenic mutations were: ATM, BRCA2, BRCA1, VHL, MSH6, APC, CHEK2, MSH2, MEN1, PALB2, and MUTYH. Thirty-one patients (30.6%) had BRCA2 mutations and twenty (19.8%) had BRCA1 mutations. Our results showed that exon 10 and exon 11 harbored 3 and 5 mutations, respectively, in BRCA1 and BRCA2 genes. Our analysis also revealed that the VHL gene significantly co-occurred with each of the BRCA2 gene (p = 0.003, event ratio 11/21), the MSH2 gene (p = 0.01, 4/10), the CHEK2 gene (p = 0.02, 4/11), and the MSH6 gene (p = 0.04, 4/12). In addition, the APC gene significantly co-occurred with the MSH2 gene (p = 0.01, 3/7). Furthermore, there was a significant mutually exclusive event between the APC gene and the ATM gene (p = 0.04, 1/36). Interestingly, we identified population specific germline mutations in genes showing potentials for targeted therapy to meet the need for incorporating precision oncology into clinical practice. For example, the mutations identified in the ATM, APC, and MSH2 genes.Multi-gene panel sequencing was used to detect the deleterious mutations associated with familial BC, which in turns mitigate the essential need for implementing next generation sequencing technologies in precision oncology to identify cancer predisposing genes. Moreover, identifying DNA repair gene mutations, with focus on non-BRCA genes, might serve as candidates for targeted therapy and will be increasingly used in precision oncology." @default.
- W4313361181 created "2023-01-06" @default.
- W4313361181 creator A5001439859 @default.
- W4313361181 creator A5024357259 @default.
- W4313361181 creator A5027508027 @default.
- W4313361181 creator A5047078549 @default.
- W4313361181 creator A5053342577 @default.
- W4313361181 creator A5054321389 @default.
- W4313361181 creator A5059331507 @default.
- W4313361181 creator A5063111673 @default.
- W4313361181 creator A5069733754 @default.
- W4313361181 creator A5074995099 @default.
- W4313361181 date "2022-12-29" @default.
- W4313361181 modified "2023-10-17" @default.
- W4313361181 title "Frequency of Pathogenic Germline Mutations in Early and Late Onset Familial Breast Cancer Patients Using Multi-Gene Panel Sequencing: An Egyptian Study" @default.
- W4313361181 cites W1940241680 @default.
- W4313361181 cites W1980740976 @default.
- W4313361181 cites W1998891209 @default.
- W4313361181 cites W1999402226 @default.
- W4313361181 cites W2048806210 @default.
- W4313361181 cites W2051978340 @default.
- W4313361181 cites W2055635652 @default.
- W4313361181 cites W2078431196 @default.
- W4313361181 cites W2124371549 @default.
- W4313361181 cites W2206281701 @default.
- W4313361181 cites W2210202376 @default.
- W4313361181 cites W2217722934 @default.
- W4313361181 cites W2282435866 @default.
- W4313361181 cites W2340335534 @default.
- W4313361181 cites W2415567782 @default.
- W4313361181 cites W2536777558 @default.
- W4313361181 cites W2575489469 @default.
- W4313361181 cites W2579423964 @default.
- W4313361181 cites W2584974716 @default.
- W4313361181 cites W2586159641 @default.
- W4313361181 cites W2588902343 @default.
- W4313361181 cites W2593676268 @default.
- W4313361181 cites W2595690372 @default.
- W4313361181 cites W2606372051 @default.
- W4313361181 cites W2614364607 @default.
- W4313361181 cites W2627871710 @default.
- W4313361181 cites W2731803318 @default.
- W4313361181 cites W2732269941 @default.
- W4313361181 cites W2737863823 @default.
- W4313361181 cites W2746993714 @default.
- W4313361181 cites W2753565653 @default.
- W4313361181 cites W2769367424 @default.
- W4313361181 cites W2770026599 @default.
- W4313361181 cites W2778497684 @default.
- W4313361181 cites W2783113646 @default.
- W4313361181 cites W2802528458 @default.
- W4313361181 cites W2807943540 @default.
- W4313361181 cites W2898088739 @default.
- W4313361181 cites W2900086599 @default.
- W4313361181 cites W2905452503 @default.
- W4313361181 cites W2914707098 @default.
- W4313361181 cites W2939196113 @default.
- W4313361181 cites W2946248359 @default.
- W4313361181 cites W2947754660 @default.
- W4313361181 cites W2957101013 @default.
- W4313361181 cites W2969983588 @default.
- W4313361181 cites W2972967236 @default.
- W4313361181 cites W2979640933 @default.
- W4313361181 cites W2997669138 @default.
- W4313361181 cites W3004669743 @default.
- W4313361181 cites W3023296125 @default.
- W4313361181 cites W3047787489 @default.
- W4313361181 cites W3083453756 @default.
- W4313361181 cites W3087819952 @default.
- W4313361181 cites W3110887898 @default.
- W4313361181 cites W3123011295 @default.
- W4313361181 cites W3137822132 @default.
- W4313361181 cites W3162543922 @default.
- W4313361181 cites W3186949303 @default.
- W4313361181 cites W4220940243 @default.
- W4313361181 cites W4232884262 @default.
- W4313361181 doi "https://doi.org/10.3390/genes14010106" @default.
- W4313361181 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36672847" @default.
- W4313361181 hasPublicationYear "2022" @default.
- W4313361181 type Work @default.
- W4313361181 citedByCount "3" @default.
- W4313361181 countsByYear W43133611812023 @default.
- W4313361181 crossrefType "journal-article" @default.
- W4313361181 hasAuthorship W4313361181A5001439859 @default.
- W4313361181 hasAuthorship W4313361181A5024357259 @default.
- W4313361181 hasAuthorship W4313361181A5027508027 @default.
- W4313361181 hasAuthorship W4313361181A5047078549 @default.
- W4313361181 hasAuthorship W4313361181A5053342577 @default.
- W4313361181 hasAuthorship W4313361181A5054321389 @default.
- W4313361181 hasAuthorship W4313361181A5059331507 @default.
- W4313361181 hasAuthorship W4313361181A5063111673 @default.
- W4313361181 hasAuthorship W4313361181A5069733754 @default.
- W4313361181 hasAuthorship W4313361181A5074995099 @default.
- W4313361181 hasBestOaLocation W43133611811 @default.
- W4313361181 hasConcept C104317684 @default.
- W4313361181 hasConcept C109825262 @default.
- W4313361181 hasConcept C121608353 @default.
- W4313361181 hasConcept C13514818 @default.